Home > Search Clinical Trials > All > Trial Details

Clinical Trial Details
A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNRI.
Clinical Trial ( IRB ) #: W23-227-1
Title: A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNRI.
Principal Investigator: Dr. Neha Jain
Description: This is an observational study for adults with Major Depressive Disorder (MDD). The purpose of this study is to collect information on participants’ well-being and how depression treatments help over the course of their study participation. No study medication is used in this observational study. Participants will continue to take their current medications as prescribed by their provider(s).
Classification:
  Psychiatry - General Adult/Mental Health (Depression, Anxiety, Etc.)
Eligibility Criteria: Adults 18 years of age or older; have a diagnosis of MDD; Have an inadequate response to SSRI/SNRI; Are in the process of starting a new treatment (medication or therapy) for depression; for additional eligibility criteria, check in with study contact.
How to Contact: Galina Prpich. Telephone: 860-679-7539 Email: prpich@uchc.edu
Enrollment Status/Comments: Enrolling/recruiting